Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ ...

Dr Ranadive’s legacy as India’s first Cell Biologist and a pioneering cancer researcher continues to inspire and influence the scientific community. Her dedication to research and her role in ...

The purpose of this study was to investigate the combination of doxorubicin with the pro-apoptotic BCL-2 inhibitor venetoclax in TNBC cell lines and to assess the role of p53 in cellular senescence ...